Enas Nabil Georgy
Giza, Egypt
NCT Number: NCT06621680
This study will be conducted to investigate the effect of connective tissue massage on premenstrual syndrome.
Trial opening soon.
Get Notified17 year–25 year
Female
Interventional
Not applicable
Giza, Egypt
Premenstrual syndrome is a collection of emotional, physiological and behavioral symptoms that develop around the end of the luteal phase and fade away with or after mensturation.
The physiological effects of connective tissue massage (CTM) are both local and general. Local effects include release of histamine from mast cells which leads to a triple response, local swelling and arteriolar dilatation mediated by local axon reflexes. The increased blood flow to the region assists resolution of subacute or chronic inflammation and reduces pain by removing nocigenic chemicals from the tissues. The mechanical distortions produced by CTM strokes help to mobilize connective tissue and improve function.
Few studies have investigated the effect of the CTM on premenstrual syndrome in adolescent females. So this study will be conducted to add new information about the effect of connective tissue massage on premenstrual syndrome, which may help adolescent females suffering from this syndrome in decreasing their symptoms, thus adding new information to the field of physical therapy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be excluded from this study if they have
All participants will receive multivitamins (vitatron) capsule once daily, for 12 weeks.
Connective tissue massage will be applied on (Sacral, lumbar, last thoracic vertebrae-T12, and subcostal regions), 2 sessions/week for 20 minutes each session for 12 weeks. Treatment will begin 3 days before menstruation to the 4th day of menstruation for 3 successive menstrual cycles.
Time frame: 3 months
Degrees of menstrual pain will be assessed using a VAS for all participants before and after treatment, which is a method of representing pain on a 10 cm linear scale.
A score of zero means "No pain" and 10 means "a very high degree of pain".
Time frame: 3 months
Severity of premenstrual symptoms will be assessed by using the Menstrual Distress Questionnaire (MDQ). Each participant will examine symptom categories (pain, concentration, water retention, behavior changes, negative effect, autonomic reaction, arousal and control) Participants are asked to report the symptoms experienced during their most recent menstrual period, using a rating scale. Responses ranged from (0) No experience of the symptom, (1) mild, (2) moderate, (3) severe and (4) very severe disabling symptoms. Overall scores are interpreted as follows: >50- mild, 50 to 70- moderate and >70 severe
Contact information is provided by the study sponsor or research team.
Enas N Georgy, Master
CONTACT
Mohamed F Abo Eleinien, professor
CONTACT
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07684495
Menstruation Disturbances, Pathologic Processes
Hurghada, Egypt
View Trial DetailsNCT07441096
Menstruation Disturbances, Pathologic Processes
San Francisco, California, United States
View Trial DetailsNCT07171814
Menstruation Disturbances, Pathologic Processes
View Trial DetailsNCT07097181
Body Awareness, Effect
Istanbul, Turkey (Türkiye)
View Trial Details